📊
PlainSight — Insightful Actions
Home · Guides · Handbooks · Cellular & molecular biology lab

🧬 Running a cell & molecular biology lab that bills

A core facility or contract lab: sequencing, imaging, cytometry and molecular work for the labs around you — the grant calendar, the recharge rate, and the reproducibility the journals now ask for.

What the market is worth

Misidentified cell lines
608 on the ICLAC Register of Misidentified Cell Lines, version 14 (15 February 2026); 560 of them with no authentic stock known, and HeLa the commonest contaminant, 145 entries (ICLAC)
Authentication
Asked for NIH expects key biological resources — cell lines, antibodies, specialty chemicals — to be authenticated, in a plan attached to every application since the January 25, 2016 due date (NIH, NOT-OD-15-103)
Postdoc stipend
$62,232 the NIH NRSA stipend for a first-year postdoctoral fellow in FY 2025 ($75,564 at seven or more years); predoctoral $28,788 (NIH, NOT-OD-25-105, May 2025)
Sequencing
Faster than Moore's law the cost of a human genome at NHGRI's sequencing centers fell faster than Moore's law from January 2008, when they moved from Sanger to second-generation instruments; NHGRI's cost series counts labor, reagents, instruments over three years and indirects (NHGRI, DNA Sequencing Costs: Data)
What a core charges
A recharge rate a university core bills its own institution's labs at a rate that recovers its direct costs, and outside and industry users more; US federal cost rules (2 CFR 200.468) require a recharge rate to break even over time, not to profit from federal awards
The grant year
September 30 the US federal fiscal year ends on September 30, and an NIH award's budget period ends on its own anniversary; the weeks before either are when labs spend what is left
Free tools
Most of them PubMed, BLAST, UniProt, the PDB, Ensembl, Reactome, Fiji, Galaxy and Bioconductor are free to use; protocols.io and Addgene's guides are free to read; Benchling is free for academics (each site's own terms)
Mycoplasma
Test on arrival a contaminated culture looks healthy under the microscope and skews every result grown in it; repositories and journals ask for a recent negative test with a cell line's data

How it actually grows

Year 0–1 One instrument, one rate, a sign-up sheet

A core starts as a shared instrument with a calendar and a rate per hour or per sample that covers service contracts, reagents and the hands that run it. Bill every job, even the favors: the record of who used what is what gets the next instrument funded. Put the rate, the turnaround and the sample requirements on one page everyone can find.

Watch out:

Years 1–3 A menu, a manager and the grant calendar

Services become a menu — Sanger and NGS, imaging hours, cytometry, authentication, mycoplasma testing, training — and the year takes the grant calendar's shape: the rush before September 30 and before budget-period ends, the quiet of late December. A manager who can plan reagent orders and instrument time around that calendar is worth more than another machine.

Watch out:

Years 3–5 Outside users and the recharge review

Industry and outside academic users pay a higher tier and steady the year, but they can't be more of the money than the institution's rules and your federal rate review allow. Review the rate yearly against actual costs, keep the subsidy explicit, and publish turnaround as a number you meet.

Watch out:

Mature A service the institution counts on

Growth is a second shift on the instruments you have, an authentication-and-QC line every lab is now asked to use, and training that turns users into careful users. Replace instruments on a schedule written down years ahead; a core whose sequencer dies in August has no September.

Watch out:

What each revenue stream is good for

Revenue streamPaysScales
NGS library prep and sequencing The line that grows: more labs sequence every year, and library prep is where a core earns its keep. Price per sample with the run share folded in, and say the turnaround. Per sample or per run share Growing
Sanger sequencing Still the daily check on a clone or a primer, in small batches. Volume slips as NGS and vendor services take the big jobs; keep it cheap and fast rather than defend it. Per reaction Slipping
Imaging and cytometry hours Confocal, flow and sorting sell hours. Assisted hours cost more and fail less; train users and sell the unassisted hour to the ones who pass. Per hour, assisted or not Steady
Molecular services qPCR plates, Westerns, plasmid preps and cloning, and the occasional CRISPR editing project priced as a project, not an hour. Per plate, blot or project Steady
Cell line authentication and mycoplasma testing Journals and NIH ask for both; a core that tests every line coming in and going out sells peace of mind by the sample. The fastest-growing line in the sample book for that reason. Per line or per sample Growing fastest
Cryo-storage and repository The only subscription a core has. Small money, but it is the money that arrives in December. Per box per month Small, recurring
Training Pays for itself twice: the fee, and the instrument time a trained user doesn't break. Per person or per course Small
Industry and outside users Steadies the year and funds the subsidy for the labs down the hall; watch the concentration — one company account can become your largest client without anyone deciding it. A higher tier A fifth of the jobs, a third of the money

If you're starting this month

  1. Authenticate every human cell line on arrival and before a paper (STR profiling against a reference), test for mycoplasma on arrival and quarterly, and keep the certificates with the line. ICLAC's register lists 608 misidentified lines; HeLa alone is 145 of them.
  2. Write the authentication plan NIH asks for (NOT-OD-15-103) once, keep it current, and attach it to every application; it is read, even though it isn't scored.
  3. Bill every job, including the department's and the favors, at the published rate. The usage record is the case for the next instrument and the defense of the recharge rate.
  4. Plan reagents and instrument time around the grant calendar: the rush before September 30 and before each lab's budget-period end, the quiet of late December.
  5. Publish turnaround as a number, meet it, and say when you can't. A core is trusted on turnaround before it is trusted on anything else.
  6. Keep one lab notebook rule for the whole core — electronic, timestamped, with the protocol version named — and keep raw instrument data for as long as the funder requires.
  7. Review the recharge rate against actual costs every year, keep the institutional subsidy explicit, and price outside and industry users on their own tier.
  8. Know your institution's biosafety, chemical and radiation rules before the first sample arrives; the core signs for what it handles.

Before you act on any of this

Nothing here is medical, safety or regulatory advice. Biosafety levels, select-agent rules, human-subjects and animal protocols, export controls on some reagents and sequences, and your institution's recharge and cost-accounting policies all apply before anything in this handbook does; follow them and your biosafety officer. Figures carry their sources and their dates. This is general information, not legal/tax advice.

Run this against real numbers → The same handbook inside the tool, on a worked example you can swap for your own spreadsheet. Free, no account.

Guides for this business

The other 33 handbooks

Figures are sourced from published industry research (IBISWorld, trade associations and regulator data) and are stated with their year. They describe typical conditions, not your situation. This is general information for business owners, not financial, tax, or legal advice.